nodes	percent_of_prediction	percent_of_DWPC	metapath
Solifenacin—Faecaloma—Epirubicin—liver cancer	0.0242	0.0261	CcSEcCtD
Solifenacin—Faecalith—Epirubicin—liver cancer	0.0242	0.0261	CcSEcCtD
Solifenacin—Dysphonia—Sorafenib—liver cancer	0.0227	0.0245	CcSEcCtD
Solifenacin—Benazepril—MTHFR—liver cancer	0.0225	1	CrCbGaD
Solifenacin—Faecaloma—Doxorubicin—liver cancer	0.0224	0.0241	CcSEcCtD
Solifenacin—Faecalith—Doxorubicin—liver cancer	0.0224	0.0241	CcSEcCtD
Solifenacin—Gastrooesophageal reflux disease—Sorafenib—liver cancer	0.0207	0.0223	CcSEcCtD
Solifenacin—Drug interaction—Sorafenib—liver cancer	0.0202	0.0217	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Sorafenib—liver cancer	0.0144	0.0155	CcSEcCtD
Solifenacin—Dry skin—Sorafenib—liver cancer	0.0124	0.0134	CcSEcCtD
Solifenacin—Abdominal pain upper—Sorafenib—liver cancer	0.0124	0.0134	CcSEcCtD
Solifenacin—Infestation—Sorafenib—liver cancer	0.0105	0.0113	CcSEcCtD
Solifenacin—Infestation NOS—Sorafenib—liver cancer	0.0105	0.0113	CcSEcCtD
Solifenacin—Renal failure—Sorafenib—liver cancer	0.0103	0.0111	CcSEcCtD
Solifenacin—Hepatobiliary disease—Sorafenib—liver cancer	0.00989	0.0107	CcSEcCtD
Solifenacin—Ileus—Epirubicin—liver cancer	0.00976	0.0105	CcSEcCtD
Solifenacin—Urinary tract disorder—Sorafenib—liver cancer	0.00927	0.01	CcSEcCtD
Solifenacin—Connective tissue disorder—Sorafenib—liver cancer	0.00923	0.00995	CcSEcCtD
Solifenacin—Urethral disorder—Sorafenib—liver cancer	0.0092	0.00992	CcSEcCtD
Solifenacin—Ileus—Doxorubicin—liver cancer	0.00903	0.00974	CcSEcCtD
Solifenacin—Erythema multiforme—Sorafenib—liver cancer	0.00888	0.00957	CcSEcCtD
Solifenacin—Cardiac disorder—Sorafenib—liver cancer	0.00871	0.00939	CcSEcCtD
Solifenacin—Angiopathy—Sorafenib—liver cancer	0.00852	0.00918	CcSEcCtD
Solifenacin—Immune system disorder—Sorafenib—liver cancer	0.00848	0.00914	CcSEcCtD
Solifenacin—Mediastinal disorder—Sorafenib—liver cancer	0.00846	0.00912	CcSEcCtD
Solifenacin—Dysphonia—Epirubicin—liver cancer	0.0084	0.00905	CcSEcCtD
Solifenacin—Mental disorder—Sorafenib—liver cancer	0.00823	0.00887	CcSEcCtD
Solifenacin—Malnutrition—Sorafenib—liver cancer	0.00817	0.00881	CcSEcCtD
Solifenacin—Delirium—Epirubicin—liver cancer	0.00803	0.00866	CcSEcCtD
Solifenacin—Dysgeusia—Sorafenib—liver cancer	0.008	0.00863	CcSEcCtD
Solifenacin—Dysphonia—Doxorubicin—liver cancer	0.00777	0.00838	CcSEcCtD
Solifenacin—Angioedema—Sorafenib—liver cancer	0.00747	0.00805	CcSEcCtD
Solifenacin—Delirium—Doxorubicin—liver cancer	0.00743	0.00801	CcSEcCtD
Solifenacin—Cough—Sorafenib—liver cancer	0.00713	0.00769	CcSEcCtD
Solifenacin—Hypertension—Sorafenib—liver cancer	0.00706	0.00761	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00691	0.00745	CcSEcCtD
Solifenacin—Hepatocellular injury—Epirubicin—liver cancer	0.00691	0.00745	CcSEcCtD
Solifenacin—Dry mouth—Sorafenib—liver cancer	0.00681	0.00734	CcSEcCtD
Solifenacin—Hyperkalaemia—Epirubicin—liver cancer	0.00679	0.00732	CcSEcCtD
Solifenacin—Cystitis noninfective—Epirubicin—liver cancer	0.00675	0.00728	CcSEcCtD
Solifenacin—Cystitis—Epirubicin—liver cancer	0.00667	0.00719	CcSEcCtD
Solifenacin—Anaphylactic shock—Sorafenib—liver cancer	0.00667	0.00719	CcSEcCtD
Solifenacin—Infection—Sorafenib—liver cancer	0.00663	0.00714	CcSEcCtD
Solifenacin—Nervous system disorder—Sorafenib—liver cancer	0.00654	0.00705	CcSEcCtD
Solifenacin—Skin disorder—Sorafenib—liver cancer	0.00648	0.00699	CcSEcCtD
Solifenacin—Hepatocellular injury—Doxorubicin—liver cancer	0.00639	0.00689	CcSEcCtD
Solifenacin—Dry eye—Epirubicin—liver cancer	0.00638	0.00688	CcSEcCtD
Solifenacin—Hyperkalaemia—Doxorubicin—liver cancer	0.00628	0.00677	CcSEcCtD
Solifenacin—Bladder pain—Epirubicin—liver cancer	0.00625	0.00674	CcSEcCtD
Solifenacin—Cystitis noninfective—Doxorubicin—liver cancer	0.00625	0.00673	CcSEcCtD
Solifenacin—Cystitis—Doxorubicin—liver cancer	0.00617	0.00666	CcSEcCtD
Solifenacin—Dry eye—Doxorubicin—liver cancer	0.00591	0.00637	CcSEcCtD
Solifenacin—Dyspepsia—Sorafenib—liver cancer	0.00587	0.00633	CcSEcCtD
Solifenacin—Decreased appetite—Sorafenib—liver cancer	0.0058	0.00625	CcSEcCtD
Solifenacin—Bladder pain—Doxorubicin—liver cancer	0.00578	0.00623	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00576	0.00621	CcSEcCtD
Solifenacin—Fatigue—Sorafenib—liver cancer	0.00575	0.0062	CcSEcCtD
Solifenacin—Constipation—Sorafenib—liver cancer	0.0057	0.00615	CcSEcCtD
Solifenacin—Gastrointestinal pain—Sorafenib—liver cancer	0.00546	0.00588	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Epirubicin—liver cancer	0.00532	0.00573	CcSEcCtD
Solifenacin—Urticaria—Sorafenib—liver cancer	0.0053	0.00571	CcSEcCtD
Solifenacin—Abdominal pain—Sorafenib—liver cancer	0.00527	0.00569	CcSEcCtD
Solifenacin—Renal impairment—Epirubicin—liver cancer	0.00527	0.00568	CcSEcCtD
Solifenacin—Dermatitis exfoliative—Doxorubicin—liver cancer	0.00492	0.0053	CcSEcCtD
Solifenacin—Hypersensitivity—Sorafenib—liver cancer	0.00492	0.0053	CcSEcCtD
Solifenacin—Renal impairment—Doxorubicin—liver cancer	0.00488	0.00526	CcSEcCtD
Solifenacin—Asthenia—Sorafenib—liver cancer	0.00479	0.00516	CcSEcCtD
Solifenacin—Pruritus—Sorafenib—liver cancer	0.00472	0.00509	CcSEcCtD
Solifenacin—Liver function test abnormal—Epirubicin—liver cancer	0.00463	0.00499	CcSEcCtD
Solifenacin—Dry skin—Epirubicin—liver cancer	0.0046	0.00496	CcSEcCtD
Solifenacin—Abdominal pain upper—Epirubicin—liver cancer	0.00458	0.00494	CcSEcCtD
Solifenacin—Muscular weakness—Epirubicin—liver cancer	0.00442	0.00477	CcSEcCtD
Solifenacin—Dizziness—Sorafenib—liver cancer	0.00441	0.00476	CcSEcCtD
Solifenacin—Influenza—Epirubicin—liver cancer	0.00434	0.00467	CcSEcCtD
Solifenacin—Liver function test abnormal—Doxorubicin—liver cancer	0.00429	0.00462	CcSEcCtD
Solifenacin—Dry skin—Doxorubicin—liver cancer	0.00425	0.00459	CcSEcCtD
Solifenacin—Vomiting—Sorafenib—liver cancer	0.00424	0.00457	CcSEcCtD
Solifenacin—Abdominal pain upper—Doxorubicin—liver cancer	0.00424	0.00457	CcSEcCtD
Solifenacin—Rash—Sorafenib—liver cancer	0.00421	0.00453	CcSEcCtD
Solifenacin—Dermatitis—Sorafenib—liver cancer	0.0042	0.00453	CcSEcCtD
Solifenacin—Headache—Sorafenib—liver cancer	0.00418	0.00451	CcSEcCtD
Solifenacin—Muscular weakness—Doxorubicin—liver cancer	0.00409	0.00441	CcSEcCtD
Solifenacin—Dysuria—Epirubicin—liver cancer	0.00405	0.00437	CcSEcCtD
Solifenacin—Influenza—Doxorubicin—liver cancer	0.00401	0.00432	CcSEcCtD
Solifenacin—Nausea—Sorafenib—liver cancer	0.00396	0.00427	CcSEcCtD
Solifenacin—Infestation NOS—Epirubicin—liver cancer	0.00387	0.00417	CcSEcCtD
Solifenacin—Infestation—Epirubicin—liver cancer	0.00387	0.00417	CcSEcCtD
Solifenacin—Renal failure—Epirubicin—liver cancer	0.0038	0.0041	CcSEcCtD
Solifenacin—Urinary tract infection—Epirubicin—liver cancer	0.00376	0.00405	CcSEcCtD
Solifenacin—Dysuria—Doxorubicin—liver cancer	0.00375	0.00404	CcSEcCtD
Solifenacin—Hepatobiliary disease—Epirubicin—liver cancer	0.00366	0.00394	CcSEcCtD
Solifenacin—Infestation NOS—Doxorubicin—liver cancer	0.00358	0.00386	CcSEcCtD
Solifenacin—Infestation—Doxorubicin—liver cancer	0.00358	0.00386	CcSEcCtD
Solifenacin—Renal failure—Doxorubicin—liver cancer	0.00352	0.00379	CcSEcCtD
Solifenacin—Urinary tract infection—Doxorubicin—liver cancer	0.00348	0.00375	CcSEcCtD
Solifenacin—Pharyngitis—Epirubicin—liver cancer	0.00344	0.00371	CcSEcCtD
Solifenacin—Urinary tract disorder—Epirubicin—liver cancer	0.00343	0.00369	CcSEcCtD
Solifenacin—Oedema peripheral—Epirubicin—liver cancer	0.00342	0.00369	CcSEcCtD
Solifenacin—Connective tissue disorder—Epirubicin—liver cancer	0.00341	0.00368	CcSEcCtD
Solifenacin—Urethral disorder—Epirubicin—liver cancer	0.0034	0.00367	CcSEcCtD
Solifenacin—Hepatobiliary disease—Doxorubicin—liver cancer	0.00338	0.00365	CcSEcCtD
Solifenacin—Erythema multiforme—Epirubicin—liver cancer	0.00328	0.00354	CcSEcCtD
Solifenacin—Eye disorder—Epirubicin—liver cancer	0.00324	0.0035	CcSEcCtD
Solifenacin—Cardiac disorder—Epirubicin—liver cancer	0.00322	0.00347	CcSEcCtD
Solifenacin—Pharyngitis—Doxorubicin—liver cancer	0.00319	0.00344	CcSEcCtD
Solifenacin—Urinary tract disorder—Doxorubicin—liver cancer	0.00317	0.00342	CcSEcCtD
Solifenacin—Oedema peripheral—Doxorubicin—liver cancer	0.00316	0.00341	CcSEcCtD
Solifenacin—Connective tissue disorder—Doxorubicin—liver cancer	0.00316	0.0034	CcSEcCtD
Solifenacin—Angiopathy—Epirubicin—liver cancer	0.00315	0.00339	CcSEcCtD
Solifenacin—Urethral disorder—Doxorubicin—liver cancer	0.00315	0.00339	CcSEcCtD
Solifenacin—Immune system disorder—Epirubicin—liver cancer	0.00313	0.00338	CcSEcCtD
Solifenacin—Mediastinal disorder—Epirubicin—liver cancer	0.00313	0.00337	CcSEcCtD
Solifenacin—Mental disorder—Epirubicin—liver cancer	0.00304	0.00328	CcSEcCtD
Solifenacin—Erythema multiforme—Doxorubicin—liver cancer	0.00304	0.00327	CcSEcCtD
Solifenacin—Malnutrition—Epirubicin—liver cancer	0.00302	0.00326	CcSEcCtD
Solifenacin—Eye disorder—Doxorubicin—liver cancer	0.003	0.00323	CcSEcCtD
Solifenacin—Cardiac disorder—Doxorubicin—liver cancer	0.00298	0.00321	CcSEcCtD
Solifenacin—Dysgeusia—Epirubicin—liver cancer	0.00296	0.00319	CcSEcCtD
Solifenacin—Angiopathy—Doxorubicin—liver cancer	0.00291	0.00314	CcSEcCtD
Solifenacin—Immune system disorder—Doxorubicin—liver cancer	0.0029	0.00313	CcSEcCtD
Solifenacin—Mediastinal disorder—Doxorubicin—liver cancer	0.00289	0.00312	CcSEcCtD
Solifenacin—Vision blurred—Epirubicin—liver cancer	0.00285	0.00307	CcSEcCtD
Solifenacin—Mental disorder—Doxorubicin—liver cancer	0.00281	0.00303	CcSEcCtD
Solifenacin—Malnutrition—Doxorubicin—liver cancer	0.0028	0.00301	CcSEcCtD
Solifenacin—Dysgeusia—Doxorubicin—liver cancer	0.00274	0.00295	CcSEcCtD
Solifenacin—Palpitations—Epirubicin—liver cancer	0.00267	0.00288	CcSEcCtD
Solifenacin—Cough—Epirubicin—liver cancer	0.00264	0.00284	CcSEcCtD
Solifenacin—Vision blurred—Doxorubicin—liver cancer	0.00263	0.00284	CcSEcCtD
Solifenacin—Hypertension—Epirubicin—liver cancer	0.00261	0.00281	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00255	0.00275	CcSEcCtD
Solifenacin—Dry mouth—Epirubicin—liver cancer	0.00252	0.00271	CcSEcCtD
Solifenacin—Confusional state—Epirubicin—liver cancer	0.00249	0.00268	CcSEcCtD
Solifenacin—Palpitations—Doxorubicin—liver cancer	0.00247	0.00266	CcSEcCtD
Solifenacin—Anaphylactic shock—Epirubicin—liver cancer	0.00247	0.00266	CcSEcCtD
Solifenacin—Infection—Epirubicin—liver cancer	0.00245	0.00264	CcSEcCtD
Solifenacin—Cough—Doxorubicin—liver cancer	0.00244	0.00263	CcSEcCtD
Solifenacin—Nervous system disorder—Epirubicin—liver cancer	0.00242	0.00261	CcSEcCtD
Solifenacin—Hypertension—Doxorubicin—liver cancer	0.00241	0.0026	CcSEcCtD
Solifenacin—Tachycardia—Epirubicin—liver cancer	0.00241	0.00259	CcSEcCtD
Solifenacin—Skin disorder—Epirubicin—liver cancer	0.00239	0.00258	CcSEcCtD
Solifenacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.00236	0.00255	CcSEcCtD
Solifenacin—Dry mouth—Doxorubicin—liver cancer	0.00233	0.00251	CcSEcCtD
Solifenacin—Confusional state—Doxorubicin—liver cancer	0.0023	0.00248	CcSEcCtD
Solifenacin—Anaphylactic shock—Doxorubicin—liver cancer	0.00228	0.00246	CcSEcCtD
Solifenacin—Infection—Doxorubicin—liver cancer	0.00227	0.00244	CcSEcCtD
Solifenacin—Nervous system disorder—Doxorubicin—liver cancer	0.00224	0.00241	CcSEcCtD
Solifenacin—Tachycardia—Doxorubicin—liver cancer	0.00223	0.0024	CcSEcCtD
Solifenacin—Skin disorder—Doxorubicin—liver cancer	0.00222	0.00239	CcSEcCtD
Solifenacin—Somnolence—Epirubicin—liver cancer	0.00219	0.00236	CcSEcCtD
Solifenacin—Dyspepsia—Epirubicin—liver cancer	0.00217	0.00234	CcSEcCtD
Solifenacin—Decreased appetite—Epirubicin—liver cancer	0.00214	0.00231	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00213	0.00229	CcSEcCtD
Solifenacin—Fatigue—Epirubicin—liver cancer	0.00213	0.00229	CcSEcCtD
Solifenacin—Constipation—Epirubicin—liver cancer	0.00211	0.00227	CcSEcCtD
Solifenacin—Feeling abnormal—Epirubicin—liver cancer	0.00203	0.00219	CcSEcCtD
Solifenacin—Somnolence—Doxorubicin—liver cancer	0.00203	0.00219	CcSEcCtD
Solifenacin—Gastrointestinal pain—Epirubicin—liver cancer	0.00202	0.00217	CcSEcCtD
Solifenacin—Dyspepsia—Doxorubicin—liver cancer	0.00201	0.00216	CcSEcCtD
Solifenacin—Decreased appetite—Doxorubicin—liver cancer	0.00198	0.00214	CcSEcCtD
Solifenacin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00197	0.00212	CcSEcCtD
Solifenacin—Fatigue—Doxorubicin—liver cancer	0.00197	0.00212	CcSEcCtD
Solifenacin—Urticaria—Epirubicin—liver cancer	0.00196	0.00211	CcSEcCtD
Solifenacin—Constipation—Doxorubicin—liver cancer	0.00195	0.0021	CcSEcCtD
Solifenacin—Abdominal pain—Epirubicin—liver cancer	0.00195	0.0021	CcSEcCtD
Solifenacin—Feeling abnormal—Doxorubicin—liver cancer	0.00188	0.00203	CcSEcCtD
Solifenacin—Gastrointestinal pain—Doxorubicin—liver cancer	0.00187	0.00201	CcSEcCtD
Solifenacin—Hypersensitivity—Epirubicin—liver cancer	0.00182	0.00196	CcSEcCtD
Solifenacin—Urticaria—Doxorubicin—liver cancer	0.00181	0.00195	CcSEcCtD
Solifenacin—Abdominal pain—Doxorubicin—liver cancer	0.0018	0.00194	CcSEcCtD
Solifenacin—Asthenia—Epirubicin—liver cancer	0.00177	0.00191	CcSEcCtD
Solifenacin—Pruritus—Epirubicin—liver cancer	0.00174	0.00188	CcSEcCtD
Solifenacin—Hypersensitivity—Doxorubicin—liver cancer	0.00168	0.00181	CcSEcCtD
Solifenacin—Asthenia—Doxorubicin—liver cancer	0.00164	0.00176	CcSEcCtD
Solifenacin—Dizziness—Epirubicin—liver cancer	0.00163	0.00176	CcSEcCtD
Solifenacin—Pruritus—Doxorubicin—liver cancer	0.00161	0.00174	CcSEcCtD
Solifenacin—Vomiting—Epirubicin—liver cancer	0.00157	0.00169	CcSEcCtD
Solifenacin—Rash—Epirubicin—liver cancer	0.00155	0.00168	CcSEcCtD
Solifenacin—Dermatitis—Epirubicin—liver cancer	0.00155	0.00167	CcSEcCtD
Solifenacin—Headache—Epirubicin—liver cancer	0.00154	0.00167	CcSEcCtD
Solifenacin—Dizziness—Doxorubicin—liver cancer	0.00151	0.00163	CcSEcCtD
Solifenacin—Nausea—Epirubicin—liver cancer	0.00146	0.00158	CcSEcCtD
Solifenacin—Vomiting—Doxorubicin—liver cancer	0.00145	0.00156	CcSEcCtD
Solifenacin—Rash—Doxorubicin—liver cancer	0.00144	0.00155	CcSEcCtD
Solifenacin—Dermatitis—Doxorubicin—liver cancer	0.00144	0.00155	CcSEcCtD
Solifenacin—Headache—Doxorubicin—liver cancer	0.00143	0.00154	CcSEcCtD
Solifenacin—Nausea—Doxorubicin—liver cancer	0.00136	0.00146	CcSEcCtD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	2.27e-05	0.000455	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PRKCE—liver cancer	2.27e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—F2—liver cancer	2.27e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CD—liver cancer	2.26e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—APC—liver cancer	2.26e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CG—liver cancer	2.26e-05	0.000454	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	2.24e-05	0.000449	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	2.18e-05	0.000437	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IGF2—liver cancer	2.18e-05	0.000436	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CB—liver cancer	2.17e-05	0.000435	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IGF2—liver cancer	2.17e-05	0.000435	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—APC—liver cancer	2.17e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CG—liver cancer	2.17e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—MTHFR—liver cancer	2.17e-05	0.000434	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	2.15e-05	0.000431	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IGF2—liver cancer	2.15e-05	0.000431	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—BRAF—liver cancer	2.13e-05	0.000426	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARA—liver cancer	2.12e-05	0.000426	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTA4—liver cancer	2.09e-05	0.000418	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—BRAF—liver cancer	2.04e-05	0.000408	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTA2—liver cancer	2.03e-05	0.000407	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CSF2—liver cancer	2.03e-05	0.000407	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—RAF1—liver cancer	2.03e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CSF2—liver cancer	2.03e-05	0.000406	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—RAF1—liver cancer	2.02e-05	0.000405	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CSF2—liver cancer	2.01e-05	0.000402	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—H2AFX—liver cancer	2e-05	0.000401	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—IL2—liver cancer	2e-05	0.000401	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—RAF1—liver cancer	2e-05	0.000401	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—H2AFX—liver cancer	2e-05	0.0004	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—IL2—liver cancer	2e-05	0.0004	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CD—liver cancer	1.99e-05	0.000399	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	1.98e-05	0.000397	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—H2AFX—liver cancer	1.98e-05	0.000396	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—IL2—liver cancer	1.98e-05	0.000396	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CB—liver cancer	1.97e-05	0.000395	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—PIK3CA—liver cancer	1.97e-05	0.000395	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—SERPINE1—liver cancer	1.97e-05	0.000394	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTA1—liver cancer	1.96e-05	0.000393	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	1.95e-05	0.000392	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—KRAS—liver cancer	1.95e-05	0.00039	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—NAT2—liver cancer	1.94e-05	0.000389	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CD—liver cancer	1.91e-05	0.000382	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—PIK3CA—liver cancer	1.89e-05	0.000378	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—SERPINE1—liver cancer	1.88e-05	0.000378	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—KRAS—liver cancer	1.87e-05	0.000374	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALDOB—liver cancer	1.86e-05	0.000373	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CG—liver cancer	1.82e-05	0.000365	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL2—liver cancer	1.82e-05	0.000364	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL2—liver cancer	1.81e-05	0.000363	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TERT—liver cancer	1.81e-05	0.000363	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TERT—liver cancer	1.81e-05	0.000362	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL2—liver cancer	1.79e-05	0.00036	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—PIK3CA—liver cancer	1.79e-05	0.000359	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TERT—liver cancer	1.79e-05	0.000358	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—RAF1—liver cancer	1.78e-05	0.000356	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CRABP1—liver cancer	1.77e-05	0.000355	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PPARG—liver cancer	1.76e-05	0.000352	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MTOR—liver cancer	1.73e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CB—liver cancer	1.73e-05	0.000348	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—PIK3CA—liver cancer	1.71e-05	0.000343	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—RAF1—liver cancer	1.7e-05	0.000341	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CB—liver cancer	1.66e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MTOR—liver cancer	1.66e-05	0.000333	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KDR—liver cancer	1.66e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—HRAS—liver cancer	1.66e-05	0.000332	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KDR—liver cancer	1.65e-05	0.000331	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK14—liver cancer	1.65e-05	0.00033	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK14—liver cancer	1.64e-05	0.000329	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KDR—liver cancer	1.64e-05	0.000328	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1B—liver cancer	1.63e-05	0.000326	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK14—liver cancer	1.62e-05	0.000326	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—ESR1—liver cancer	1.61e-05	0.000324	CbGpPWpGaD
Solifenacin—CHRM4—GPCR downstream signaling—AKT1—liver cancer	1.61e-05	0.000323	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—ESR1—liver cancer	1.61e-05	0.000322	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CD—liver cancer	1.6e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CASP3—liver cancer	1.6e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—F2—liver cancer	1.59e-05	0.00032	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—ESR1—liver cancer	1.59e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL2—liver cancer	1.59e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—F2—liver cancer	1.59e-05	0.000319	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—HRAS—liver cancer	1.59e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—IL6—liver cancer	1.59e-05	0.000318	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—ALB—liver cancer	1.58e-05	0.000316	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—F2—liver cancer	1.57e-05	0.000315	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1B—liver cancer	1.56e-05	0.000312	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CCND1—liver cancer	1.55e-05	0.000311	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HPGDS—liver cancer	1.55e-05	0.000311	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—JUN—liver cancer	1.55e-05	0.00031	CbGpPWpGaD
Solifenacin—CHRM5—GPCR downstream signaling—AKT1—liver cancer	1.54e-05	0.000309	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CTNNB1—liver cancer	1.54e-05	0.000308	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CASP3—liver cancer	1.53e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CG—liver cancer	1.53e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—APC—liver cancer	1.53e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL2—liver cancer	1.53e-05	0.000306	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—APC—liver cancer	1.52e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CG—liver cancer	1.52e-05	0.000305	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—IL6—liver cancer	1.52e-05	0.000304	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MMP9—liver cancer	1.51e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—APC—liver cancer	1.51e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CG—liver cancer	1.51e-05	0.000302	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—CDKN1A—liver cancer	1.5e-05	0.000301	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CCND1—liver cancer	1.49e-05	0.000298	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—JUN—liver cancer	1.48e-05	0.000297	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CTNNB1—liver cancer	1.47e-05	0.000295	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MAPK8—liver cancer	1.47e-05	0.000294	CbGpPWpGaD
Solifenacin—CHRM4—Signaling by GPCR—AKT1—liver cancer	1.46e-05	0.000293	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MMP9—liver cancer	1.44e-05	0.000289	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—CDKN1A—liver cancer	1.44e-05	0.000288	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—BRAF—liver cancer	1.43e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—BRAF—liver cancer	1.43e-05	0.000287	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—BRAF—liver cancer	1.42e-05	0.000284	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MAPK8—liver cancer	1.4e-05	0.000281	CbGpPWpGaD
Solifenacin—CHRM5—Signaling by GPCR—AKT1—liver cancer	1.4e-05	0.000281	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CB—liver cancer	1.39e-05	0.000279	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PSMA4—liver cancer	1.38e-05	0.000277	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PSMD10—liver cancer	1.38e-05	0.000277	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—VEGFA—liver cancer	1.35e-05	0.000271	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT2—liver cancer	1.34e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CD—liver cancer	1.34e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—STAT3—liver cancer	1.34e-05	0.000269	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CD—liver cancer	1.34e-05	0.000268	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	1.33e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—SERPINE1—liver cancer	1.33e-05	0.000266	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—PIK3CA—liver cancer	1.32e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CD—liver cancer	1.32e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—SERPINE1—liver cancer	1.32e-05	0.000265	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—KRAS—liver cancer	1.31e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	1.31e-05	0.000263	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—SERPINE1—liver cancer	1.31e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—KRAS—liver cancer	1.31e-05	0.000262	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—KRAS—liver cancer	1.3e-05	0.00026	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—VEGFA—liver cancer	1.3e-05	0.00026	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—STAT3—liver cancer	1.28e-05	0.000257	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP2E1—liver cancer	1.26e-05	0.000253	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—MYC—liver cancer	1.25e-05	0.00025	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TGFB1—liver cancer	1.24e-05	0.000249	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	1.21e-05	0.000242	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—PIK3CA—liver cancer	1.2e-05	0.000241	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—RAF1—liver cancer	1.2e-05	0.00024	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—RAF1—liver cancer	1.19e-05	0.000239	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—MYC—liver cancer	1.19e-05	0.000239	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	1.19e-05	0.000239	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TGFB1—liver cancer	1.19e-05	0.000238	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYCS—liver cancer	1.18e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—RAF1—liver cancer	1.18e-05	0.000237	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CB—liver cancer	1.17e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MTOR—liver cancer	1.17e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CB—liver cancer	1.17e-05	0.000234	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MTOR—liver cancer	1.17e-05	0.000234	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GGT1—liver cancer	1.16e-05	0.000233	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GOT1—liver cancer	1.16e-05	0.000233	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MTOR—liver cancer	1.15e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CB—liver cancer	1.15e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—KRAS—liver cancer	1.15e-05	0.000231	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—HRAS—liver cancer	1.12e-05	0.000224	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—HRAS—liver cancer	1.11e-05	0.000223	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—HRAS—liver cancer	1.1e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—KRAS—liver cancer	1.1e-05	0.000221	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1B—liver cancer	1.1e-05	0.00022	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1B—liver cancer	1.09e-05	0.000219	CbGpPWpGaD
Solifenacin—CHRM1—GPCR downstream signaling—AKT1—liver cancer	1.09e-05	0.000218	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1B—liver cancer	1.08e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM3—GPCR downstream signaling—AKT1—liver cancer	1.08e-05	0.000217	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CASP3—liver cancer	1.08e-05	0.000216	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL2—liver cancer	1.07e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CASP3—liver cancer	1.07e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM2—GPCR downstream signaling—AKT1—liver cancer	1.07e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL2—liver cancer	1.07e-05	0.000215	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—IL6—liver cancer	1.07e-05	0.000214	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—IL6—liver cancer	1.07e-05	0.000213	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CASP3—liver cancer	1.06e-05	0.000213	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL2—liver cancer	1.06e-05	0.000212	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—PIK3CA—liver cancer	1.06e-05	0.000212	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—IL6—liver cancer	1.06e-05	0.000211	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CCND1—liver cancer	1.05e-05	0.00021	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—JUN—liver cancer	1.04e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CCND1—liver cancer	1.04e-05	0.000209	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTP1—liver cancer	1.04e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—JUN—liver cancer	1.04e-05	0.000209	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CTNNB1—liver cancer	1.04e-05	0.000208	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CCND1—liver cancer	1.03e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CTNNB1—liver cancer	1.03e-05	0.000207	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—JUN—liver cancer	1.03e-05	0.000207	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—HMOX1—liver cancer	1.03e-05	0.000206	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CTNNB1—liver cancer	1.02e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—TP53—liver cancer	1.02e-05	0.000205	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MMP9—liver cancer	1.02e-05	0.000204	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MMP9—liver cancer	1.01e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—CDKN1A—liver cancer	1.01e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—PIK3CA—liver cancer	1.01e-05	0.000203	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—CDKN1A—liver cancer	1.01e-05	0.000202	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MMP9—liver cancer	1e-05	0.000201	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—CDKN1A—liver cancer	1e-05	0.0002	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MAPK8—liver cancer	9.89e-06	0.000198	CbGpPWpGaD
Solifenacin—CHRM1—Signaling by GPCR—AKT1—liver cancer	9.86e-06	0.000198	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MAPK8—liver cancer	9.86e-06	0.000197	CbGpPWpGaD
Solifenacin—CHRM3—Signaling by GPCR—AKT1—liver cancer	9.83e-06	0.000197	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—TP53—liver cancer	9.8e-06	0.000196	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—HRAS—liver cancer	9.78e-06	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MAPK8—liver cancer	9.76e-06	0.000196	CbGpPWpGaD
Solifenacin—CHRM2—Signaling by GPCR—AKT1—liver cancer	9.73e-06	0.000195	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—GSTM1—liver cancer	9.58e-06	0.000192	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—HRAS—liver cancer	9.37e-06	0.000188	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—IL6—liver cancer	9.36e-06	0.000188	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—VEGFA—liver cancer	9.13e-06	0.000183	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—VEGFA—liver cancer	9.1e-06	0.000182	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—CYP1A1—liver cancer	9.08e-06	0.000182	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—STAT3—liver cancer	9.04e-06	0.000181	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—VEGFA—liver cancer	9.01e-06	0.000181	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—STAT3—liver cancer	9.01e-06	0.000181	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—IL6—liver cancer	8.97e-06	0.00018	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—STAT3—liver cancer	8.92e-06	0.000179	CbGpPWpGaD
Solifenacin—CHRM4—Signaling Pathways—AKT1—liver cancer	8.64e-06	0.000173	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—PIK3CA—liver cancer	8.5e-06	0.00017	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—MTHFR—liver cancer	8.47e-06	0.00017	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—MYC—liver cancer	8.4e-06	0.000168	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TGFB1—liver cancer	8.38e-06	0.000168	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—MYC—liver cancer	8.37e-06	0.000168	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TGFB1—liver cancer	8.35e-06	0.000167	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARA—liver cancer	8.31e-06	0.000166	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—MYC—liver cancer	8.29e-06	0.000166	CbGpPWpGaD
Solifenacin—CHRM5—Signaling Pathways—AKT1—liver cancer	8.27e-06	0.000166	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TGFB1—liver cancer	8.27e-06	0.000166	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—KRAS—liver cancer	7.76e-06	0.000155	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—KRAS—liver cancer	7.74e-06	0.000155	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—KRAS—liver cancer	7.66e-06	0.000153	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—PIK3CA—liver cancer	7.13e-06	0.000143	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CG—liver cancer	7.11e-06	0.000143	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—PIK3CA—liver cancer	7.11e-06	0.000142	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—PIK3CA—liver cancer	7.04e-06	0.000141	CbGpPWpGaD
Solifenacin—CHRM3—Metabolism—AKT1—liver cancer	6.94e-06	0.000139	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—TP53—liver cancer	6.9e-06	0.000138	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—TP53—liver cancer	6.88e-06	0.000138	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PPARG—liver cancer	6.87e-06	0.000138	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—TP53—liver cancer	6.81e-06	0.000136	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—HRAS—liver cancer	6.6e-06	0.000132	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—HRAS—liver cancer	6.58e-06	0.000132	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—HRAS—liver cancer	6.51e-06	0.00013	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—IL6—liver cancer	6.31e-06	0.000126	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—IL6—liver cancer	6.29e-06	0.000126	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CD—liver cancer	6.25e-06	0.000125	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—IL6—liver cancer	6.23e-06	0.000125	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—ALB—liver cancer	6.17e-06	0.000124	CbGpPWpGaD
Solifenacin—CHRM1—Signaling Pathways—AKT1—liver cancer	5.82e-06	0.000117	CbGpPWpGaD
Solifenacin—CHRM3—Signaling Pathways—AKT1—liver cancer	5.81e-06	0.000116	CbGpPWpGaD
Solifenacin—CHRM2—Signaling Pathways—AKT1—liver cancer	5.75e-06	0.000115	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CB—liver cancer	5.45e-06	0.000109	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—PIK3CA—liver cancer	3.32e-06	6.66e-05	CbGpPWpGaD
Solifenacin—CYP3A4—Metabolism—AKT1—liver cancer	2.71e-06	5.44e-05	CbGpPWpGaD
